Review





Similar Products

90
ATCC pxp2 backbone
PU.1 regulates miR-146a in vivo. (A) MiR-146a expression in WT hematopoietic precursors and mature myeloid cells. miR-146a qRT-PCR was performed from FACS-purified HSCs (LSKs), common myeloid progenitors (CMPs; Lin−Sca-1−c-Kit+CD34+FcγRII/IIIlow), splenic granulocytes (Gra; Gr1+CD11b+), and splenic macrophages (Mac; Gr1−CD11b+). Data were compared with U6 RNA ± SD miR-146a and PU.1 mRNA expression in the indicated FACS-purified hematopoietic populations from WT and PU.1 KD animals. (B) MiR-146a was analyzed compared with U6 RNA, and PU.1 expression was determined relative to β-actin. **P < .001 by Student t test. (C) A 375-bp fragment containing the PU.1-binding site at 10 kb upstream of the genomic miR-146 locus was inserted in the <t>pXP2</t> luciferase plasmid pXP2-(-)10kb. Mutation of the PU.1 motif (ctgaggaagt to ctgaccaagt) in the pXP2-(-)10kb construct, as indicated by the crossed-out PU.1 symbol in the pictogram, led to a marked reduction in reporter activity in transiently transfected myeloid RAW264.7 cells. Relative expression was determined 48 hours after transfection compared with pXP2 empty basal fluorescence activity (n = 3). **P < .001 by Student t test. (D) RAW264.7 cells carrying a stable PU.1 KD shRNA showed significantly lower miR146 promoter activity than plain RAW264.7 cells when transiently transfected with the WT pXP2-(-)10kb construct. Reporter activity of plain RAW264.7 cells was set to 100% (n = 3). **P < .001 by Student t test. (E) PU.1 expression in untreated and stably PU.1-shRNA–transfected RAW264.7 cells in Western blot normalized to levels of tubulin. Error bars indicate SD.
Pxp2 Backbone, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pxp2 backbone/product/ATCC
Average 90 stars, based on 1 article reviews
pxp2 backbone - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

92
Novus Biologicals nbp2 37577
PU.1 regulates miR-146a in vivo. (A) MiR-146a expression in WT hematopoietic precursors and mature myeloid cells. miR-146a qRT-PCR was performed from FACS-purified HSCs (LSKs), common myeloid progenitors (CMPs; Lin−Sca-1−c-Kit+CD34+FcγRII/IIIlow), splenic granulocytes (Gra; Gr1+CD11b+), and splenic macrophages (Mac; Gr1−CD11b+). Data were compared with U6 RNA ± SD miR-146a and PU.1 mRNA expression in the indicated FACS-purified hematopoietic populations from WT and PU.1 KD animals. (B) MiR-146a was analyzed compared with U6 RNA, and PU.1 expression was determined relative to β-actin. **P < .001 by Student t test. (C) A 375-bp fragment containing the PU.1-binding site at 10 kb upstream of the genomic miR-146 locus was inserted in the <t>pXP2</t> luciferase plasmid pXP2-(-)10kb. Mutation of the PU.1 motif (ctgaggaagt to ctgaccaagt) in the pXP2-(-)10kb construct, as indicated by the crossed-out PU.1 symbol in the pictogram, led to a marked reduction in reporter activity in transiently transfected myeloid RAW264.7 cells. Relative expression was determined 48 hours after transfection compared with pXP2 empty basal fluorescence activity (n = 3). **P < .001 by Student t test. (D) RAW264.7 cells carrying a stable PU.1 KD shRNA showed significantly lower miR146 promoter activity than plain RAW264.7 cells when transiently transfected with the WT pXP2-(-)10kb construct. Reporter activity of plain RAW264.7 cells was set to 100% (n = 3). **P < .001 by Student t test. (E) PU.1 expression in untreated and stably PU.1-shRNA–transfected RAW264.7 cells in Western blot normalized to levels of tubulin. Error bars indicate SD.
Nbp2 37577, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nbp2 37577/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
nbp2 37577 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

90
Novus Biologicals beta-actin antibody ac-15 nbp2-37577 clone: 4e7
PU.1 regulates miR-146a in vivo. (A) MiR-146a expression in WT hematopoietic precursors and mature myeloid cells. miR-146a qRT-PCR was performed from FACS-purified HSCs (LSKs), common myeloid progenitors (CMPs; Lin−Sca-1−c-Kit+CD34+FcγRII/IIIlow), splenic granulocytes (Gra; Gr1+CD11b+), and splenic macrophages (Mac; Gr1−CD11b+). Data were compared with U6 RNA ± SD miR-146a and PU.1 mRNA expression in the indicated FACS-purified hematopoietic populations from WT and PU.1 KD animals. (B) MiR-146a was analyzed compared with U6 RNA, and PU.1 expression was determined relative to β-actin. **P < .001 by Student t test. (C) A 375-bp fragment containing the PU.1-binding site at 10 kb upstream of the genomic miR-146 locus was inserted in the <t>pXP2</t> luciferase plasmid pXP2-(-)10kb. Mutation of the PU.1 motif (ctgaggaagt to ctgaccaagt) in the pXP2-(-)10kb construct, as indicated by the crossed-out PU.1 symbol in the pictogram, led to a marked reduction in reporter activity in transiently transfected myeloid RAW264.7 cells. Relative expression was determined 48 hours after transfection compared with pXP2 empty basal fluorescence activity (n = 3). **P < .001 by Student t test. (D) RAW264.7 cells carrying a stable PU.1 KD shRNA showed significantly lower miR146 promoter activity than plain RAW264.7 cells when transiently transfected with the WT pXP2-(-)10kb construct. Reporter activity of plain RAW264.7 cells was set to 100% (n = 3). **P < .001 by Student t test. (E) PU.1 expression in untreated and stably PU.1-shRNA–transfected RAW264.7 cells in Western blot normalized to levels of tubulin. Error bars indicate SD.
Beta Actin Antibody Ac 15 Nbp2 37577 Clone: 4e7, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/beta-actin antibody ac-15 nbp2-37577 clone: 4e7/product/Novus Biologicals
Average 90 stars, based on 1 article reviews
beta-actin antibody ac-15 nbp2-37577 clone: 4e7 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

92
Bio-Techne corporation aif antibody (4e7) - bsa free
PU.1 regulates miR-146a in vivo. (A) MiR-146a expression in WT hematopoietic precursors and mature myeloid cells. miR-146a qRT-PCR was performed from FACS-purified HSCs (LSKs), common myeloid progenitors (CMPs; Lin−Sca-1−c-Kit+CD34+FcγRII/IIIlow), splenic granulocytes (Gra; Gr1+CD11b+), and splenic macrophages (Mac; Gr1−CD11b+). Data were compared with U6 RNA ± SD miR-146a and PU.1 mRNA expression in the indicated FACS-purified hematopoietic populations from WT and PU.1 KD animals. (B) MiR-146a was analyzed compared with U6 RNA, and PU.1 expression was determined relative to β-actin. **P < .001 by Student t test. (C) A 375-bp fragment containing the PU.1-binding site at 10 kb upstream of the genomic miR-146 locus was inserted in the <t>pXP2</t> luciferase plasmid pXP2-(-)10kb. Mutation of the PU.1 motif (ctgaggaagt to ctgaccaagt) in the pXP2-(-)10kb construct, as indicated by the crossed-out PU.1 symbol in the pictogram, led to a marked reduction in reporter activity in transiently transfected myeloid RAW264.7 cells. Relative expression was determined 48 hours after transfection compared with pXP2 empty basal fluorescence activity (n = 3). **P < .001 by Student t test. (D) RAW264.7 cells carrying a stable PU.1 KD shRNA showed significantly lower miR146 promoter activity than plain RAW264.7 cells when transiently transfected with the WT pXP2-(-)10kb construct. Reporter activity of plain RAW264.7 cells was set to 100% (n = 3). **P < .001 by Student t test. (E) PU.1 expression in untreated and stably PU.1-shRNA–transfected RAW264.7 cells in Western blot normalized to levels of tubulin. Error bars indicate SD.
Aif Antibody (4e7) Bsa Free, supplied by Bio-Techne corporation, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aif antibody (4e7) - bsa free/product/Bio-Techne corporation
Average 92 stars, based on 1 article reviews
aif antibody (4e7) - bsa free - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

91
Novus Biologicals novus biologicals nbp2 37577 4e7
PU.1 regulates miR-146a in vivo. (A) MiR-146a expression in WT hematopoietic precursors and mature myeloid cells. miR-146a qRT-PCR was performed from FACS-purified HSCs (LSKs), common myeloid progenitors (CMPs; Lin−Sca-1−c-Kit+CD34+FcγRII/IIIlow), splenic granulocytes (Gra; Gr1+CD11b+), and splenic macrophages (Mac; Gr1−CD11b+). Data were compared with U6 RNA ± SD miR-146a and PU.1 mRNA expression in the indicated FACS-purified hematopoietic populations from WT and PU.1 KD animals. (B) MiR-146a was analyzed compared with U6 RNA, and PU.1 expression was determined relative to β-actin. **P < .001 by Student t test. (C) A 375-bp fragment containing the PU.1-binding site at 10 kb upstream of the genomic miR-146 locus was inserted in the <t>pXP2</t> luciferase plasmid pXP2-(-)10kb. Mutation of the PU.1 motif (ctgaggaagt to ctgaccaagt) in the pXP2-(-)10kb construct, as indicated by the crossed-out PU.1 symbol in the pictogram, led to a marked reduction in reporter activity in transiently transfected myeloid RAW264.7 cells. Relative expression was determined 48 hours after transfection compared with pXP2 empty basal fluorescence activity (n = 3). **P < .001 by Student t test. (D) RAW264.7 cells carrying a stable PU.1 KD shRNA showed significantly lower miR146 promoter activity than plain RAW264.7 cells when transiently transfected with the WT pXP2-(-)10kb construct. Reporter activity of plain RAW264.7 cells was set to 100% (n = 3). **P < .001 by Student t test. (E) PU.1 expression in untreated and stably PU.1-shRNA–transfected RAW264.7 cells in Western blot normalized to levels of tubulin. Error bars indicate SD.
Novus Biologicals Nbp2 37577 4e7, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/novus biologicals nbp2 37577 4e7/product/Novus Biologicals
Average 91 stars, based on 1 article reviews
novus biologicals nbp2 37577 4e7 - by Bioz Stars, 2026-02
91/100 stars
  Buy from Supplier

92
Novus Biologicals aif
PU.1 regulates miR-146a in vivo. (A) MiR-146a expression in WT hematopoietic precursors and mature myeloid cells. miR-146a qRT-PCR was performed from FACS-purified HSCs (LSKs), common myeloid progenitors (CMPs; Lin−Sca-1−c-Kit+CD34+FcγRII/IIIlow), splenic granulocytes (Gra; Gr1+CD11b+), and splenic macrophages (Mac; Gr1−CD11b+). Data were compared with U6 RNA ± SD miR-146a and PU.1 mRNA expression in the indicated FACS-purified hematopoietic populations from WT and PU.1 KD animals. (B) MiR-146a was analyzed compared with U6 RNA, and PU.1 expression was determined relative to β-actin. **P < .001 by Student t test. (C) A 375-bp fragment containing the PU.1-binding site at 10 kb upstream of the genomic miR-146 locus was inserted in the <t>pXP2</t> luciferase plasmid pXP2-(-)10kb. Mutation of the PU.1 motif (ctgaggaagt to ctgaccaagt) in the pXP2-(-)10kb construct, as indicated by the crossed-out PU.1 symbol in the pictogram, led to a marked reduction in reporter activity in transiently transfected myeloid RAW264.7 cells. Relative expression was determined 48 hours after transfection compared with pXP2 empty basal fluorescence activity (n = 3). **P < .001 by Student t test. (D) RAW264.7 cells carrying a stable PU.1 KD shRNA showed significantly lower miR146 promoter activity than plain RAW264.7 cells when transiently transfected with the WT pXP2-(-)10kb construct. Reporter activity of plain RAW264.7 cells was set to 100% (n = 3). **P < .001 by Student t test. (E) PU.1 expression in untreated and stably PU.1-shRNA–transfected RAW264.7 cells in Western blot normalized to levels of tubulin. Error bars indicate SD.
Aif, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/aif/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
aif - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

90
ATCC vector pxp2 plasmid
a SNU1235, SNU1047, HT29, and LS180 cells lines were treated with the indicated concentration of drugs for 2 h and the presence of IL-8 was detected by RT-qPCR in all cell lines. Results were evaluated as ΔΔct of IL-8 relative to RPL19 and expressed as the ratio assuming the levels in the control as 1.0. Results of a representative experiment out of three independent experiments performed are shown. b Transcription factor binding regions in the IL-8 gene promoter retained in the different luciferase reporter plasmids. c Cell lines were co-transfected with 100 ng luc-reporter vector and 10 ng pRL-TK. Cells were harvested for luc assay 24 h post-transfection. <t>pXP2</t> empty vector plasmid was used as a control. Results represent the average of three independent experiments. p -values indicate statistically significant differences ( p < 0.05 by 2-tailed Student’s t test) for the comparison between each reporter construct and the full promoter sequence (546-luc).
Vector Pxp2 Plasmid, supplied by ATCC, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/vector pxp2 plasmid/product/ATCC
Average 90 stars, based on 1 article reviews
vector pxp2 plasmid - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

92
Novus Biologicals apoptosis inducing factor
a SNU1235, SNU1047, HT29, and LS180 cells lines were treated with the indicated concentration of drugs for 2 h and the presence of IL-8 was detected by RT-qPCR in all cell lines. Results were evaluated as ΔΔct of IL-8 relative to RPL19 and expressed as the ratio assuming the levels in the control as 1.0. Results of a representative experiment out of three independent experiments performed are shown. b Transcription factor binding regions in the IL-8 gene promoter retained in the different luciferase reporter plasmids. c Cell lines were co-transfected with 100 ng luc-reporter vector and 10 ng pRL-TK. Cells were harvested for luc assay 24 h post-transfection. <t>pXP2</t> empty vector plasmid was used as a control. Results represent the average of three independent experiments. p -values indicate statistically significant differences ( p < 0.05 by 2-tailed Student’s t test) for the comparison between each reporter construct and the full promoter sequence (546-luc).
Apoptosis Inducing Factor, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apoptosis inducing factor/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
apoptosis inducing factor - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier

Image Search Results


PU.1 regulates miR-146a in vivo. (A) MiR-146a expression in WT hematopoietic precursors and mature myeloid cells. miR-146a qRT-PCR was performed from FACS-purified HSCs (LSKs), common myeloid progenitors (CMPs; Lin−Sca-1−c-Kit+CD34+FcγRII/IIIlow), splenic granulocytes (Gra; Gr1+CD11b+), and splenic macrophages (Mac; Gr1−CD11b+). Data were compared with U6 RNA ± SD miR-146a and PU.1 mRNA expression in the indicated FACS-purified hematopoietic populations from WT and PU.1 KD animals. (B) MiR-146a was analyzed compared with U6 RNA, and PU.1 expression was determined relative to β-actin. **P < .001 by Student t test. (C) A 375-bp fragment containing the PU.1-binding site at 10 kb upstream of the genomic miR-146 locus was inserted in the pXP2 luciferase plasmid pXP2-(-)10kb. Mutation of the PU.1 motif (ctgaggaagt to ctgaccaagt) in the pXP2-(-)10kb construct, as indicated by the crossed-out PU.1 symbol in the pictogram, led to a marked reduction in reporter activity in transiently transfected myeloid RAW264.7 cells. Relative expression was determined 48 hours after transfection compared with pXP2 empty basal fluorescence activity (n = 3). **P < .001 by Student t test. (D) RAW264.7 cells carrying a stable PU.1 KD shRNA showed significantly lower miR146 promoter activity than plain RAW264.7 cells when transiently transfected with the WT pXP2-(-)10kb construct. Reporter activity of plain RAW264.7 cells was set to 100% (n = 3). **P < .001 by Student t test. (E) PU.1 expression in untreated and stably PU.1-shRNA–transfected RAW264.7 cells in Western blot normalized to levels of tubulin. Error bars indicate SD.

Journal: Blood

Article Title: Macrophage development from HSCs requires PU.1-coordinated microRNA expression

doi: 10.1182/blood-2011-02-335141

Figure Lengend Snippet: PU.1 regulates miR-146a in vivo. (A) MiR-146a expression in WT hematopoietic precursors and mature myeloid cells. miR-146a qRT-PCR was performed from FACS-purified HSCs (LSKs), common myeloid progenitors (CMPs; Lin−Sca-1−c-Kit+CD34+FcγRII/IIIlow), splenic granulocytes (Gra; Gr1+CD11b+), and splenic macrophages (Mac; Gr1−CD11b+). Data were compared with U6 RNA ± SD miR-146a and PU.1 mRNA expression in the indicated FACS-purified hematopoietic populations from WT and PU.1 KD animals. (B) MiR-146a was analyzed compared with U6 RNA, and PU.1 expression was determined relative to β-actin. **P < .001 by Student t test. (C) A 375-bp fragment containing the PU.1-binding site at 10 kb upstream of the genomic miR-146 locus was inserted in the pXP2 luciferase plasmid pXP2-(-)10kb. Mutation of the PU.1 motif (ctgaggaagt to ctgaccaagt) in the pXP2-(-)10kb construct, as indicated by the crossed-out PU.1 symbol in the pictogram, led to a marked reduction in reporter activity in transiently transfected myeloid RAW264.7 cells. Relative expression was determined 48 hours after transfection compared with pXP2 empty basal fluorescence activity (n = 3). **P < .001 by Student t test. (D) RAW264.7 cells carrying a stable PU.1 KD shRNA showed significantly lower miR146 promoter activity than plain RAW264.7 cells when transiently transfected with the WT pXP2-(-)10kb construct. Reporter activity of plain RAW264.7 cells was set to 100% (n = 3). **P < .001 by Student t test. (E) PU.1 expression in untreated and stably PU.1-shRNA–transfected RAW264.7 cells in Western blot normalized to levels of tubulin. Error bars indicate SD.

Article Snippet: A 375-bp genomic fragment located 10 kb upstream of miR-146a was PCR amplified (primer forward: 5′-ctcgaggagccggaatagaaggttcc-3′; primer reverse: 5′-aagcttaatgttaaattgaggtttttggtcg-3′) and subcloned into the pXP2 backbone (American Type Culture Collection no. 37577) via Xho I/ Hin dIII.

Techniques: In Vivo, Expressing, Quantitative RT-PCR, Purification, Binding Assay, Luciferase, Plasmid Preparation, Mutagenesis, Construct, Activity Assay, Transfection, Fluorescence, shRNA, Stable Transfection, Western Blot

a SNU1235, SNU1047, HT29, and LS180 cells lines were treated with the indicated concentration of drugs for 2 h and the presence of IL-8 was detected by RT-qPCR in all cell lines. Results were evaluated as ΔΔct of IL-8 relative to RPL19 and expressed as the ratio assuming the levels in the control as 1.0. Results of a representative experiment out of three independent experiments performed are shown. b Transcription factor binding regions in the IL-8 gene promoter retained in the different luciferase reporter plasmids. c Cell lines were co-transfected with 100 ng luc-reporter vector and 10 ng pRL-TK. Cells were harvested for luc assay 24 h post-transfection. pXP2 empty vector plasmid was used as a control. Results represent the average of three independent experiments. p -values indicate statistically significant differences ( p < 0.05 by 2-tailed Student’s t test) for the comparison between each reporter construct and the full promoter sequence (546-luc).

Journal: Communications Biology

Article Title: BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer

doi: 10.1038/s42003-020-01263-y

Figure Lengend Snippet: a SNU1235, SNU1047, HT29, and LS180 cells lines were treated with the indicated concentration of drugs for 2 h and the presence of IL-8 was detected by RT-qPCR in all cell lines. Results were evaluated as ΔΔct of IL-8 relative to RPL19 and expressed as the ratio assuming the levels in the control as 1.0. Results of a representative experiment out of three independent experiments performed are shown. b Transcription factor binding regions in the IL-8 gene promoter retained in the different luciferase reporter plasmids. c Cell lines were co-transfected with 100 ng luc-reporter vector and 10 ng pRL-TK. Cells were harvested for luc assay 24 h post-transfection. pXP2 empty vector plasmid was used as a control. Results represent the average of three independent experiments. p -values indicate statistically significant differences ( p < 0.05 by 2-tailed Student’s t test) for the comparison between each reporter construct and the full promoter sequence (546-luc).

Article Snippet: The empty vector pXP2 plasmid in Escherichia coli (ATCC) was been extracted with QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany) following the manufacturer’s instructions and used as a control.

Techniques: Concentration Assay, Quantitative RT-PCR, Control, Binding Assay, Luciferase, Transfection, Plasmid Preparation, Comparison, Construct, Sequencing

LS180 cell line was treated with fixed doses of dabrafenib (D) and trametinib (T) for 8 h, as indicated. a Whole LS180 lysate was immunoprecipitated with either anti-CHOP antibodies or control IgG and analyzed by WB using specific antibodies, as indicated; WB of the whole cell lysate are reported as control. LS180 chromatin was immunoprecipitated with anti-CHOP ( b ), anti-RNA Polymerase II ( c , d ) or anti-Acetyl-Histone H4 ( e ) antibodies or with control IgG and analyzed by RT-qPCR with primers specific for CHOP-binding region and TATA box of the IL-8 gene promoter. Results of a representative experiment out of three independent experiments performed are shown. f Cell lines were co-transfected with 100 ng luc-reporter vector and 10 ng pRL-TK. Cells were harvested for luc assay 24 h post-transfection and treated with fixed doses of D and T for 24 h, as indicated. pXP2 empty vector plasmid was used as a control. Results of a representative experiment out of three independent experiments performed are shown.

Journal: Communications Biology

Article Title: BRAF status modulates Interelukin-8 expression through a CHOP-dependent mechanism in colorectal cancer

doi: 10.1038/s42003-020-01263-y

Figure Lengend Snippet: LS180 cell line was treated with fixed doses of dabrafenib (D) and trametinib (T) for 8 h, as indicated. a Whole LS180 lysate was immunoprecipitated with either anti-CHOP antibodies or control IgG and analyzed by WB using specific antibodies, as indicated; WB of the whole cell lysate are reported as control. LS180 chromatin was immunoprecipitated with anti-CHOP ( b ), anti-RNA Polymerase II ( c , d ) or anti-Acetyl-Histone H4 ( e ) antibodies or with control IgG and analyzed by RT-qPCR with primers specific for CHOP-binding region and TATA box of the IL-8 gene promoter. Results of a representative experiment out of three independent experiments performed are shown. f Cell lines were co-transfected with 100 ng luc-reporter vector and 10 ng pRL-TK. Cells were harvested for luc assay 24 h post-transfection and treated with fixed doses of D and T for 24 h, as indicated. pXP2 empty vector plasmid was used as a control. Results of a representative experiment out of three independent experiments performed are shown.

Article Snippet: The empty vector pXP2 plasmid in Escherichia coli (ATCC) was been extracted with QIAprep Spin Miniprep Kit (Qiagen, Hilden, Germany) following the manufacturer’s instructions and used as a control.

Techniques: Immunoprecipitation, Control, Quantitative RT-PCR, Binding Assay, Transfection, Plasmid Preparation